Full Text View
Tabular View
No Study Results Posted
Related Studies
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
This study has been completed.
Study NCT00241722   Information provided by Cubist Pharmaceuticals

First Received on October 17, 2005.   Last Updated on March 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bowel Dysfunction
Constipation
Additional conditions recognized in this trial
Gastrointestinal Diseases
Intestinal Diseases
More general conditions related to this trial
Digestive System Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
alvimopan
Additional drug interventions recognized in this trial
Analgesics, Opioid
More general drug interventions related to this trial
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Cubist Pharmaceuticals
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services